Abshire Martha, Dennison Himmelfarb Cheryl R, Russell Stuart D
Johns Hopkins University School of Nursing, Baltimore, Maryland.
Johns Hopkins University School of Nursing, Baltimore, Maryland; Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Card Fail. 2014 Dec;20(12):973-83. doi: 10.1016/j.cardfail.2014.08.011. Epub 2014 Aug 28.
The prevalence of advanced heart failure (HF) is increasing because of the aging population and improvements in HF management strategies. Left ventricular assist device (LVAD) technology and management continue to advance rapidly, and it is anticipated that the number of LVAD implants will increase. LVADs have been demonstrated to extend life and improve outcomes in patients with advanced HF. The purpose of this article is to review and synthesize the evidence on impact of LVAD therapy on functional status. Significant functional gains were demonstrated in patients supported by LVAD throughout the 1st year, with most improvement in distance walked and peak oxygen consumption demonstrated in the 1st 6 months. Interventions to enhance exercise performance have had inconsistent effects on functional status. Poor exercise performance was associated with increased risk of adverse events. Functional status improved with LVAD therapy, although performance remained substantially reduced compared with age-adjusted norms. There is tremendous need to enhance our understanding of factors influencing functional outcomes in this high-risk population.
由于人口老龄化和心力衰竭(HF)管理策略的改进,晚期心力衰竭的患病率正在上升。左心室辅助装置(LVAD)技术和管理持续快速发展,预计LVAD植入数量将会增加。LVAD已被证明可延长晚期HF患者的生命并改善其预后。本文旨在回顾和综合关于LVAD治疗对功能状态影响的证据。在接受LVAD支持的患者中,第一年期间功能有显著改善,其中步行距离和峰值耗氧量的最大改善出现在前6个月。增强运动能力的干预措施对功能状态的影响并不一致。运动能力差与不良事件风险增加相关。LVAD治疗可改善功能状态,尽管与年龄校正后的标准相比,其表现仍大幅降低。迫切需要加强我们对影响这一高危人群功能结局因素的理解。